Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012376
Status:
COMPLETED
Last Update Posted:
2013-01-09
First Post:
2001-03-03
Brief Title:
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Adult Acute Myeloid Leukemia |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Blastic Phase Chronic Myelogenous Leukemia |
| Chronic Myelomonocytic Leukemia |
| Chronic Phase Chronic Myelogenous Leukemia |
| Paroxysmal Nocturnal Hemoglobinuria |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Myeloid Leukemia |
| Refractory Anemia |
| Refractory Anemia With Ringed Sideroblasts |
| Relapsing Chronic Myelogenous Leukemia |
| Thrombocytopenia |
Keywords: